Form 4: OptimizeRx Corp: Chief Revenue Officer Brian Clark McCarthy Reports Stock Option and Restricted Stock Unit Transactions

Brian Clark McCarthy, Chief Revenue Officer of OptimizeRx Corp, reports acquisition of stock options and restricted stock units.

Summary

• On August 2, 2024, Brian Clark McCarthy, the Chief Revenue Officer of OptimizeRx Corp, reported transactions involving stock options and restricted stock units.
• McCarthy acquired 18,677 stock options with an exercise price of $10.49, vesting in three annual installments starting August 2, 2025, and expiring on August 2, 2027.
• He also acquired 9,533 restricted stock units, each representing a contingent right to receive one share of OptimizeRx's common stock, vesting in three annual installments starting August 2, 2025, with any unvested units forfeited after August 2, 2027.
• The reporting person directly owns 18,677 shares of common stock.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of stock options and restricted stock units granted to a key executive. It doesn't inherently indicate positive or negative performance, but rather aligns the executive's interests with the company's.

Positives

• The acquisition of stock options and restricted stock units by a key executive may indicate confidence in the company's future performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track potential alignment of interests between management and shareholders.

Stakeholder Impact

• Shareholders can monitor insider transactions to gauge management's confidence in the company.

Key Dates